Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Apr;29(4):805–809. doi: 10.1128/jcm.29.4.805-809.1991

Serological follow-up of patients involved in a localized outbreak of leptospirosis.

R Lupidi 1, M Cinco 1, D Balanzin 1, E Delprete 1, P E Varaldo 1
PMCID: PMC269874  PMID: 1890181

Abstract

Eighteen patients involved in a localized outbreak of leptospirosis were subjected to a serological follow-up study over a 5-year period. Four distinct sets of sera from all patients and a fifth sample obtained from 10 of them were examined by the microscopic agglutination test (MAT) for demonstration of leptospiral antibodies. The test was carried out by using live leptospires from reference strains of 17 Leptospira interrogans serovars known to occur in Italy. In all cases, the highest titers of agglutinins were recorded against one or more of the three Australis group serovars tested (australis, bratislava, and lora). The highest antibody levels were reached soon after the acute phase of infection in some patients but only after some months in others. Titers then tended to recede with varying rapidity, but titers against the Australis group serovars were still detectable in some patients after 5 years. Coagglutinins against serovars of other serogroups were detected, generally at low levels, in the early sets of sera of most patients, but tended to disappear in the late-set sera. Specific immunoglobulin M (IgM) and IgG against the three Australis group serovars were determined in most serum samples from 16 patients by solid-phase enzyme immunoassay (EIA). In general, EIA titers were considerably lower than MAT titers, but there was a certain patient-to-patient variability in both the IgM/IgG ratio and the evolution and persistence of the two immunoglobulin classes. Since all the evidence indicated that the initial outbreak from a single source, the observed patient-to-patient variability in the progress of both MAT and EIA titers appeared to be attributable to factors inherent in the individual patients. Cross agglutination absorption tests, aimed at retrospectively determining to which of the Australis group serovars the outbreak-specific infecting strain belonged, were performed with six serum samples from different patients. Most absorbed sera seemed to originate from an australis or lora infection, but it was not possible to discriminate conclusively between the two serovars.

Full text

PDF
805

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler B., Faine S. The antibodies involved in the human immune response to leptospiral infection. J Med Microbiol. 1978 Nov;11(4):387–400. doi: 10.1099/00222615-11-4-387. [DOI] [PubMed] [Google Scholar]
  2. Adler B., Murphy A. M., Locarnini S. A., Faine S. Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay. J Clin Microbiol. 1980 May;11(5):452–457. doi: 10.1128/jcm.11.5.452-457.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cacciapuoti B., Ciceroni L., Maffei C., Di Stanislao F., Strusi P., Calegari L., Lupidi R., Scalise G., Cagnoni G., Renga G. A waterborne outbreak of leptospirosis. Am J Epidemiol. 1987 Sep;126(3):535–545. doi: 10.1093/oxfordjournals.aje.a114686. [DOI] [PubMed] [Google Scholar]
  4. Chernukha Y. G., Shishkina Z. S., Baryshev P. M., Kokovin I. L. The dynamics of IgM- and IgG-antibodies in leptospiral infection in man. Zentralbl Bakteriol Orig A. 1976 Nov;236(2-3):336–343. [PubMed] [Google Scholar]
  5. Ciceroni L., Pinto A., Cacciapuoti B. Recent trends in human leptospirosis in Italy. Eur J Epidemiol. 1988 Mar;4(1):49–54. doi: 10.1007/BF00152692. [DOI] [PubMed] [Google Scholar]
  6. Cinco M., Banfi E., Panfili E. Heterogeneity of lipopolysaccharide banding patterns in Leptospira spp. J Gen Microbiol. 1986 Apr;132(4):1135–1138. doi: 10.1099/00221287-132-4-1135. [DOI] [PubMed] [Google Scholar]
  7. Cinco M., Banfi E., Stornello C., Campo F., Korver H. First human isolate of Leptospira interrogans as serovar bratislava in Italy. FEMS Microbiol Immunol. 1989 Dec;1(8-9):499–503. doi: 10.1111/j.1574-6968.1989.tb02441.x. [DOI] [PubMed] [Google Scholar]
  8. Crevatin D., Banfi E., Crotti D., Ruaro E., Cinco M. Serosurvey on the presence of leptospiral agglutinins in humans in Northern Italy. Eur J Epidemiol. 1986 Mar;2(1):44–47. doi: 10.1007/BF00152717. [DOI] [PubMed] [Google Scholar]
  9. Terpstra W. J., Ligthart G. S., Schoone G. J. ELISA for the detection of specific IgM and IgG in human leptospirosis. J Gen Microbiol. 1985 Feb;131(2):377–385. doi: 10.1099/00221287-131-2-377. [DOI] [PubMed] [Google Scholar]
  10. Terpstra W. J., Ligthart G. S., Schoone G. J. Serodiagnosis of human leptospirosis by enzyme-linked-immunosorrbent-assay (ELISA). Zentralbl Bakteriol A. 1980 Aug;247(3):400–405. [PubMed] [Google Scholar]
  11. Turner L. H. Leptospirosis. II. Serology. Trans R Soc Trop Med Hyg. 1968;62(6):880–899. doi: 10.1016/0035-9203(68)90017-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES